SOLICITATION NOTICE
R -- Access to Data on Pharmaceutical Sales, Promotional and Advertising Data
- Notice Date
- 12/2/2005
- Notice Type
- Solicitation Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, MD, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- Reference-Number-1009855
- Response Due
- 1/17/2006
- Archive Date
- 2/1/2006
- Description
- The FDA intends to issue a solicitation for this requirement on December 16, 2005. This is not a request for a formal proposal and responses to this publication are not solicited. The anticipated NAICS Code for this acquisition is 541990 with a size standard of $6M. The solicitation will be for access to data representing pharmaceutical sales, promotional, and advertising strategies at a national level in the U.S. Please note that FDA is not interested in developing this database and expects any qualified organization to own the data as well as the means to access the data. A firm fixed price, commercial item type contract is contemplated. The expected period of performance is one base year plus two, one-year options. Contract Goals: A. Provide FDA personnel with real-time, unlimited, immediate, direct, multi-user, desktop access to currently existing, commercially available, data with the capability of providing national-level estimates of pharmaceutical sales. B. Data concerning sales and promotional information shall include current data on product- and substance- specific sales to health care institutions. Updated information on sales shall be available on a monthly and yearly basis. Historical sales data shall also be available for trending and forecasting. C. Provide FDA personnel with the ability to use these data to analyze and describe national patterns of pharmaceutical sales through the use of projection or other appropriate methodologies that are scientifically sound and transparent to FDA personnel. D. Provide FDA personnel with national estimates of product sales, sampling and promotional expenditures data as well as the content and message of pharmaceutical detailing and advertising campaigns. A short term trial subscription for a maximum of four FDA evaluators for evaluation of product performance, at no cost to the FDA, to the full, commercially available version of the database will be required. Access to the data for this trial subscription shall last a minimum of 30 days, and shall include direct access, documentation, and technical support for the entire trial subscription period. No further information regarding the solicitation is available at this time.
- Place of Performance
- Address: Rockville MD
- Record
- SN00943554-W 20051204/051202211820 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |